Gyre Therapeutics, Inc. Restructuring and Related Cost, Number of Positions Eliminated
Gyre Therapeutics, Inc. (GYRE) reported Restructuring and Related Cost, Number of Positions Eliminated of 22 Employee for the 1-month period ending 2022-03-31, per its 10-Q filed 2023-10-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2023-10-26
- Gyre Therapeutics, Inc. restructuring and related cost, number of positions eliminated for the quarter ending 2015-06-30 was 3.00 Employee.
- Gyre Therapeutics, Inc. restructuring and related cost, number of positions eliminated for the quarter ending 2015-03-31 was 5.00 Employee.
- Gyre Therapeutics, Inc. restructuring and related cost, number of positions eliminated for the quarter ending 2014-12-31 was 7.00 Employee.
Employee
| Period end | Restructuring and Related Cost, Number of Positions Eliminated | Restructuring and Related Cost, Number of Positions Eliminated 1 month | Restructuring and Related Cost, Number of Positions Eliminated 3 month | Restructuring and Related Cost, Number of Positions Eliminated 6 month | Restructuring and Related Cost, Number of Positions Eliminated 9 month |
|---|---|---|---|---|---|
| 2022-03-31 | 22.00 Employee 10-Q · filed 2023-10-26 | ||||
| 2015-06-30 | 3.00 Employee 10-Q · filed 2015-07-31 | ||||
| 2015-03-31 | 5.00 Employee 10-Q · filed 2015-07-31 | ||||
| 2014-12-31 | 7.00 Employee 10-K · filed 2015-03-16 | ||||
| 2012-10-08 | 27.00 Employee 10-K · filed 2015-03-16 | ||||
| 2012-09-30 | 65.00 Employee 10-Q · filed 2012-11-08 | ||||
| 2012-06-30 | 65.00 Employee 10-Q · filed 2012-08-09 | ||||
| 2012-04-25 | 65.00 Employee 10-K · filed 2015-03-16 |
Person
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 0 month | Restructuring and Related Cost, Number of Positions Eliminated 1 month |
|---|---|---|
| 2012-10-08 | 27.00 Person 10-K · filed 2014-03-14 | 27.00 Person 10-Q · filed 2013-11-06 |
| 2012-04-25 | 65.00 Person 10-K · filed 2014-03-14 | 65.00 Person 10-Q · filed 2013-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |